Hengrui and Kailera have been vocal about positioning the drug as being capable of improving the clinical profile of existing ...

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...

In another big-ticket licensing deal with a Chinese biotech, AstraZeneca has claimed rights to a drug candidate for chronic ...

It’s exciting news in an orphan indication which currently lacks any approved treatment, and Dr Hans Lee, director of ...

Marcus Evans announces The Evolution Summit, taking place September 28-29, 2026, at Park Hyatt Aviara Resort, Golf Club & Spa ...

Vera Therapeutics has won FDA approval for Trutakna, a BAFF/APRIL inhibitor for IgA nephropathy (IgAN) that will compete with ...

The EU is asking for feedback on measures proposed by Sanofi to address concerns about a marketing campaign for a flu vaccine ...

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These ...

Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...

Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the ...

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO, whilst ...

Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...